Syndax Pharmaceuticals Inc
Syndax Reports Third Quarter 2026 Financial Results and Provides Business Update
Total revenue of $83.3 million in 3Q26, an 82% year-over-year increase –
Company newsroom
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
1 releases
Company newsroom
NASDAQ:SNDX
1 releases
Total revenue of $83.3 million in 3Q26, an 82% year-over-year increase –